Delivery Order SPE2DB20D1100-SPE2DB25FA9Z5

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,105.05, is a delivery order contract for the supply of Testosterone 1% (25mg/2.5g) in packs of 2.5g. The contract has a completion date of February 6, 2025 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,282.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Testosterone 1% (25mg/2.5g) pharmaceutical products. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of September 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. The contract is likely...
This federal contract award, valued at $2,132.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Testosterone 1% (25mg/2.5g) pharmaceutical products. It is a firm fixed-price delivery order contract with a completion date of February 10, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,493.52, is for the delivery of Testosterone 1% (50 mg/5 g) in a 5 g package. The contract is a firm fixed-price delivery order with a completion date of March 10, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,642.58, is for the delivery of testosterone 1% (50 mg/5 g) in packages of 5 grams. This is a firm fixed-price delivery order contract with a completion date of February 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,940.66 firm fixed-price delivery order is for the supply of testosterone 1% (25mg/2.5g) medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,325.34, is for the delivery of testosterone 1% (25mg/2.5g) pharmaceutical products. The contract has a fixed-price, firm-fixed-price pricing type and a completion date of January 8, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,117.37, is for the delivery of 4563347537 ! TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM. The contract has a completion date of January 18, 2024 and is a Firm Fixed Price Delivery Order. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.46 firm-fixed-price delivery order is for the supply of testosterone 1% (25mg/2.5g) pharmaceutical products. The contract has a completion date of November 1, 2024 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Testosterone 1% (50 mg/5 g) drug product. The $1,334.43 firm fixed-price delivery order has an ultimate completion date of October 9, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, for the provision of a wide range...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA9Z5
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,839.12, is for the delivery of Testosterone 1% (25mg/2.5g) packaged units of 2.5 grams. The contract is a Firm Fixed Price Delivery Order with a completion date of March 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 6/6/25, 9:46 AM